文献速递产科生殖医学

子痫前期IVF妊娠中母体与胎儿血红素结合蛋白及α1-微球蛋白浓度与胚胎移植时黄体存在与否的关系

Maternal and fetal haemopexin and α1-microglobulin concentrations in pre-eclamptic IVF pregnancies according to presence of corpus luteum at embryo transfer.
PubMed 文献 · Reprod Biomed Online · 2022-01-18

病例对照研究纳入160例单胎妊娠,比较自然妊娠、有黄体IVF妊娠及无黄体IVF妊娠合并子痫前期时母体与脐血血红素结合蛋白和α1-微球蛋白浓度。有黄体IVF妊娠母体血红素结合蛋白在血压正常和子痫前期中均高于自然妊娠;无黄体IVF妊娠子痫前期母体血红素结合蛋白低于有黄体IVF妊娠。作者认为黄体活动可能影响围产结局,需未来研究。

要点

  • 有黄体IVF妊娠血压正常者母体血红素结合蛋白高于自然妊娠(P=0.038)。
  • 有黄体IVF妊娠子痫前期者母体血红素结合蛋白高于自然妊娠(P=0.011)。
  • 无黄体IVF妊娠子痫前期者母体血红素结合蛋白低于有黄体IVF妊娠(P=0.002)。

核心结论

  • 胚胎移植时有黄体与无黄体妊娠之间血红素清除蛋白的生理差异支持黄体活动可能影响围产结局的假说。
  • 未来需研究应用潜在策略以形成黄体是否可减少与IVF程序化周期相关的围产期并发症。

研究设计与样本

  • 病例对照研究纳入160例单胎妊娠:54例自然妊娠,50例新鲜胚胎移植或自然周期冻胚移植(有黄体)的IVF妊娠,56例新鲜卵子捐赠或程序化周期冻胚移植(无黄体)的IVF妊娠。
  • 妊娠进一步分为血压正常、子痫前期和重度子痫前期。
  • 采用ELISA法测定分娩时采集的母体血浆和脐血血浆血红素清除蛋白浓度。

主要发现

  • 校正后,有黄体IVF妊娠母体血红素结合蛋白在血压正常(P=0.038)和子痫前期(P=0.011)人群中均高于自然妊娠。
  • 子痫前期中,无黄体IVF妊娠母体血红素结合蛋白低于有黄体IVF妊娠(P=0.002)。
  • 仅重度子痫前期中,无黄体IVF妊娠母体α1-微球蛋白高于自然妊娠(P=0.014)和有黄体IVF妊娠(P=0.041)。
  • 脐血中,子痫前期有黄体IVF妊娠血红素结合蛋白高于自然妊娠(P=0.039)。
  • 血压正常人群中,无黄体IVF妊娠脐血α1-微球蛋白高于有黄体IVF妊娠(P<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Do pregnancies with corpus luteum show different maternal and fetal plasma concentrations of the scavenger proteins haemopexin and α1-microglobulin compared with pregnancies without corpus luteum in preeclampsia? DESIGN: Case-control study of 160 singleton pregnancies: 54 naturally conceived, 50 by IVF after fresh embryo transfer or frozen embryo transfer (FET) in natural cycle (presence of corpus luteum) and 56 after fresh oocyte donation or FET in programmed cycles (absence of corpus luteum). Pregnancies were subclassified into normotensive, preeclampsia and severe preeclampsia cases. Heme-scavenger concentrations were measured by ELISA in maternal and cord plasma collected at delivery. RESULTS: After adjustment, maternal haemopexin was higher in IVF with corpus luteum than in naturally conceived pregnancies in normotensive (P = 0.038) and preeclampsia (P = 0.011) populations, and lower in preeclampsia for IVF pregnancies lacking corpus luteum compared with IVF with corpus luteum (P = 0.002). Maternal α1-microglobulin levels were higher in the absence of corpus luteum only in severe cases of preeclampsia compared with naturally conceived pregnancies (P = 0.014) and IVF with corpus luteum pregnancies (P = 0.041). In cord blood, haemopexin was higher in IVF with corpus luteum compared with naturally conceived pregnancies in preeclampsia (P = 0.039) and α1-microglobulin was higher in the group lacking corpus luteum compared with IVF with corpus luteum in the normotensive population (P < 0.001). CONCLUSIONS: The physiological differences shown for these heme-scavengers between pregnancies after embryo transfer in the presence or absence of corpus luteum support the hypothesis that corpus luteum activity could influence perinatal outcomes. Future research is needed on whether applying potential strategies to develop a corpus luteum might reduce the perinatal complications associated with programmed cycles of IVF.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Boutet ML, Youssef L, Erlandsson L, et al. Maternal and fetal haemopexin and α1-microglobulin concentrations in pre-eclamptic IVF pregnancies according to presence of corpus luteum at embryo transfer. Reprod Biomed Online. 2022. PMID: 35461763. doi:10.1016/j.rbmo.2022.01.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。